Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years
Main Authors: | , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2018
|